1. Cyclotron Radiopharmaceuticals Production at the V.G.Khlopin Radium Institute
- Author
-
B. K. Kudelin, V. A. Jakovlev, E. A. Gromova, L. M. Solin, and T. S. Potapova
- Subjects
Radium ,chemistry.chemical_compound ,chemistry ,Sodium iodide ,Radiochemistry ,Iodine-123 ,chemistry.chemical_element ,Sodium iodohippurate ,Nuclear chemistry ,Iodine compounds - Abstract
For more than 10 years Radium Institute is producing radiopharmaceuticals for St. Petersburg (Russia) hospitals. We have developed technologies for sodium iodide, sodium iodohippurate, MIBG and BMIPP, labeled by iodine‐123, and gallium‐67 citrate. Radionuclidic purity of 99,98% is reached for radiopharmaceuticals labeled by iodine‐123. Radionuclidic purity is over 99.9% for gallium‐67 citrate on the date of delivery. Radiochemical purity of 95% and more is reached through the application of appropriate technologies for each RPH. It takes no longer than 4 hours for all technologies. Over 150,000 patients were investigated.
- Published
- 2003
- Full Text
- View/download PDF